How can my friend obtain long-term care after treating TNBC?

Question

Hello doctor,

My friend had a large breast lump that grew over six months. She also experienced nipple discharge, swollen lymph nodes in her armpit, generalized weakness, and unexplained weight loss. She underwent several diagnostic tests, which showed advanced-stage (stage III) triple-negative breast cancer with spread to nearby lymph nodes. Though this is an aggressive case, how might earlier detection have altered the treatment approach and prognosis?

She was reluctant to get tested, despite our repeated advice, and now she is worried because she is the primary source of income for her household. Please let me know if the treatment plan is appropriate, which includes undergoing neoadjuvant chemotherapy, mastectomy, post-surgical chemotherapy, and participation in a clinical trial with PD-L1 inhibitors as immunotherapy.

How does this type of treatment work to combat the cancer's spread and improve outcomes? Considering the challenging recovery process, what strategies can be employed to manage side effects, support her, and optimize long-term care, including physical and emotional rehabilitation?

Kindly guide.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and understood your concern.

Firstly, I would like to inform you that early detection could have significantly changed the course of treatment and prognosis. If the cancer had been caught at an earlier stage, it might have been localized, making it more responsive to treatment. This could have led to less invasive options, potentially avoiding lymph node spread and reducing the intensity of chemotherapy. Earlier intervention often results in better survival rates.

From what you have described, her treatment approach of neoadjuvant chemotherapy followed by surgery (mastectomy) and then post-surgical chemotherapy, along with immunotherapy, sounds appropriate for advanced triple-negative breast cancer (TNBC).

Neoadjuvant chemotherapy is used to shrink the tumor before surgery, making it easier to remove while also addressing any micrometastasis that may not yet be detectable. A mastectomy is often necessary when the tumor is large or when there is lymph node involvement, as in her case. Post-surgical (adjuvant) chemotherapy aims to eliminate any remaining cancer cells that might still be circulating in her body, thereby reducing the risk of recurrence.

Including PD-L1 (Programmed Death-Ligand 1) inhibitors as part of her immunotherapy can improve outcomes for some patients with triple-negative breast cancer, especially those who are PD-L1 positive. In combination with chemotherapy, it can enhance the overall effectiveness of the treatment by reducing the chances of metastasis or recurrence.

Managing the side effects of chemotherapy, such as fatigue, nausea, hair loss, and weakened immune function, is crucial. Physical rehabilitation will also be important post-surgery, especially if she undergoes a mastectomy. She may need physiotherapy to regain strength and mobility in her upper body, particularly if an extensive lymph node dissection is performed.

Emotional and psychological support will be essential. Speaking to a counselor can be beneficial. It is important for her to maintain a healthy diet, get adequate rest, and engage in light physical activity as advised by her doctor.

I suggest she regularly follow up with her oncologist and healthcare professional.

Kindly follow up if you have more doubts.

Thank you.